Details for New Drug Application (NDA): 021565
✉ Email this page to a colleague
The generic ingredient in ELESTAT is epinastine hydrochloride. There are six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the epinastine hydrochloride profile page.
Summary for 021565
Tradename: | ELESTAT |
Applicant: | Allergan |
Ingredient: | epinastine hydrochloride |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | 0.05% | ||||
Approval Date: | Oct 16, 2003 | TE: | RLD: | Yes |
Expired US Patents for NDA 021565
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Allergan | ELESTAT | epinastine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 021565-001 | Oct 16, 2003 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription